Impact of epidermal growth factor receptor, mesenchymal-epithelial transition factor, and insulin-like growth factor receptor 1 expression on survival of patients with oral and oropharyngeal cancer

British Journal of Oral and Maxillofacial Surgery

Volumn 51, Issue 3, 2013, Pages 234-240

  Perisanidis, Christos ^a   Wrba, Fritz ^a   Brandstetter, Anita ^a   Kornek, Gabriela ^a   Mitchell, David ^b   Seemann, Rudolf ^a   Selzer, Edgar ^a   Ewers, Rolf ^a   Filipits, Martin ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MID YORKSHIRE HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Biomarkers; Immunohistochemistry; Oral and oropharyngeal cancer; Prognosis

Indexed keywords

BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUOROURACIL; MITOMYCIN; PARAFFIN; SCATTER FACTOR RECEPTOR; SOMATOMEDIN C RECEPTOR;

ADJUVANT CHEMORADIOTHERAPY; ADULT; ADVANCED CANCER; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER PROGNOSIS; CANCER SIZE; CANCER SURVIVAL; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL FEATURE; CONTINUOUS INFUSION; CORRELATION ANALYSIS; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HEAD AND NECK CARCINOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; OROPHARYNX CARCINOMA; OVERALL SURVIVAL; PRIMARY TUMOR; PROTEIN EXPRESSION; PROTEIN TARGETING; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SURVIVAL PREDICTION; TREATMENT RESPONSE;

ADULT; AGE FACTORS; AGED; ALCOHOL DRINKING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOADJUVANT THERAPY; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MET; RADIOTHERAPY DOSAGE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, IGF TYPE 1; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84875267545     PISSN: 02664356     EISSN: 15321940     Source Type: Journal    
DOI: 10.1016/j.bjoms.2012.06.009     Document Type: Article

References (25)

1. K. Sargeran, H. Murtomaa, S.M. Safavi, M.M. Vehkalahti, and O. Teronen Survival after diagnosis of cancer of the oral cavity British Journal of Oral and Maxillofacial Surgery 46 2008 187 191
2. E.E. Cohen Role of epidermal growth factor receptor pathway-targeted therapy in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck Journal of Clinical Oncology 24 2006 2659 2665
3. S. Mayor MET inhibitors: translating from bench to bedside Lancet Oncology 12 2011 14
4. R. Baserga, F. Peruzzi, and K. Reiss The IGF-1 receptor in cancer biology International Journal of Cancer 107 2003 873 877
5. F. Ciardiello, and G. Tortora Epidermal growth factor receptor (EGFR) as a target in cancer therapy: understanding the role of receptor expression and other molecular determinants that could influence the response to anti-EGFR drugs European Journal of Cancer 39 2003 1348 1354
6. T. Lopez, and D. Hanahan Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis Cancer Cell 1 2002 339 353
7. C. Birchmeier, W. Birchmeier, E. Gherardi, and G.F. Vande Woude Met, metastasis, motility and more Nature Reviews Molecular Cell Biology 4 2003 915 925
8. M.V. Karamouzis, P.A. Konstantinopoulos, and A.G. Papavassiliou Targeting MET as a strategy to overcome crosstalk-related resistance to EGFR inhibitors Lancet Oncology 10 2009 709 717
9. J. van der Veeken, S. Oliveira, R.M. Schiffelers, G. Storm, P.M. van Bergen En Henegouwen, and R.C. Roovers Crosstalk between epidermal growth factor receptor- and insulin-like growth factor-1 receptor signaling: implications for cancer therapy Current Cancer Drug Targets 9 2009 748 760
10. J. Rubin Grandis, M.F. Melhem, W.E. Gooding, R. Day, V.A. Holst, and M.M. Wagener Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival Journal of the National Cancer Institute 90 1998 824 832
11. C.H. Kim, Y.W. Koh, J.H. Han, J.W. Kim, J.S. Lee, and S.J. Baek c-Met expression as an indicator of survival outcome in patients with oral tongue carcinoma Head and Neck 32 2010 1655 1664
12. L. Lo Muzio, R. Leonardi, M.D. Mignogna, G. Pannone, C. Rubini, and T. Pieramici Scatter factor receptor (c-Met) as possible prognostic factor in patients with oral squamous cell carcinoma Anticancer Research 24 2004 1063 1069
13. P.C. Lara, E. Bordon, A. Rey, M. Moreno, M. Lloret, and L.A. Henriquez-Hernandez IGF-1R expression predicts clinical outcome in patients with locally advanced oral squamous cell carcinoma Oral Oncology 47 2011 615 619
14. O.M. Braun, B. Neumeister, W. Popp, R. Scherrer, E. Dobrowsky, and W. Dobrowsky Histologic tumor regression grades in squamous cell carcinoma of the head and neck after preoperative radiochemotherapy Cancer 63 1989 1097 1100
15. C. Perisanidis, B. Perisanidis, F. Wrba, A. Brandstetter, S. El Gazzar, and N. Papadogeorgakis Evaluation of immunohistochemical expression of p53, p21, p27, cyclin D1, and Ki67 in oral and oropharyngeal squamous cell carcinoma Journal of Oral Pathology and Medicine 41 2012 40 46
16. R. Pirker, J.R. Pereira, J. von Pawel, M. Krzakowski, R. Ramlau, and K. Park EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study Lancet Oncology 13 2012 33 42
17. S. Kalyankrishna, and J. Rubin Grandis Epidermal growth factor receptor biology in head and neck cancer Journal of Clinical Oncology 24 2006 2666 2672
18. T.Y. Seiwert, R. Jagadeeswaran, L. Faoro, V. Janamanchi, V. Nallasura, and M. El Dinali The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma Cancer Research 69 2009 3021 3031
19. Y. Yuan, X. Zhou, J. Song, X. Qiu, J. Li, and L. Ye Expression and clinical significance of epidermal growth factor receptor and type 1 insulin-like growth factor receptor in nasopharyngeal carcinoma Annals of Otology, Rhinology and Laryngology 117 2008 192 200
20. J. Rubin Grandis, M.F. Melhem, E.L. Barnes, and D.J. Tweardy Quantitative immunohistochemical analysis of transforming growth factor-α and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck Cancer 78 1996 1284 1292
21. Y. Nakata, N. Uzawa, K. Takahashi, J. Sumino, C. Michikawa, and H. Sato EGFR gene copy number alteration is a better prognostic indicator than protein overexpression in oral tongue squamous cell carcinomas European Journal of Cancer 47 2011 2364 2372
22. S.M. Bentzen, B.M. Atasoy, F.M. Daley, S. Dische, P.I. Richman, and M.I. Saunders Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial Journal of Clinical Oncology 23 2005 5560 5567
23. H. Xu, L.P. Stabile, C.T. Gubish, W.E. Gooding, J. Rubin Grandis, and J.M. Siegfried Dual blockade of EGFR and c-Met abrogates redundant signaling and proliferation in head and neck carcinoma cells Clinical Cancer Research 17 2011 4425 4438
24. M.J. Jameson, A.D. Beckler, L.E. Taniguchi, A. Allak, L.B. Vanwagner, and N.G. Lee Activation of the insulin-like growth factor-1 receptor induces resistance to epidermal growth factor receptor antagonism in head and neck squamous carcinoma cells Molecular Cancer Therapeutics 10 2011 2124 2134
25. National Institutes of Health. Clinical trials registry. Identifier: NCT00957853. Available at: < http://www.clinicaltrials.gov >.